Cure8 research brief
The project could reveal a new neuro-immune circuit (IL-17A acting on enteric neurons) that promotes tissue protection during intestinal inflammation, suggesting novel non-immunosuppressive therapeutic targets for IBD.
Researchers studying neuro-immune interactions, microbiome–gut research, and immune-pathway biology; clinicians interested in future IBD therapeutics; patients and advocates following mechanistic IBD research.
The grant describes preliminary mouse data showing that enteric neurogenesis occurs during recovery from colitis and that newly formed neurons express CGRP and ADM2, neuropeptides linked to tissue protection.
The investigators will test whether IL-17A from CD4+ T cells acting on neuronal IL-17RA drives this neurogenesis and contributes to reduced disease severity in murine models.
Planned work and scope Aims include defining how CGRP- and ADM2-expressing enteric neurons are regulated by the microbiota and inflammation, and using genetic and viral tools to delete IL-17RA in enteric neurons or IL-17A in CD4+ T cells to probe causal roles.
This is a funded preclinical project using mouse models; it does not report human trial results or clinical recommendations.
This is a funded preclinical research project reporting preliminary murine data and outlining planned experiments. Findings are not clinical results and translation to humans will require further validation.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Genetic ancestry can influence IBD risk and disease course, and most prior studies focused on European populations.
A validated AI biomarker that predicts which IBD treatments are likely to work could reduce trial-and-error in treatment choices, potentially shortening time to effective therapy for people with Crohn's disease or...
Based on the title and source metadata, this appears to be a clinical study related to Crohn's disease, Ulcerative colitis, and Inflammatory bowel disease. The original article is from degruyterbrill.com.
